Nevertheless, in this present study, we demonstrated that overexpressing Sirt1 protects mice against arterial stiffening in response to WD, suggesting that Sirt1 activation may be a novel therapeutic target for treating obesity‐associated increases in arterial stiffness and deleterious arterial remodeling. The gene discussed is SIRT1; the disease is obesity due to melanocortin 4 receptor deficiency.